Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,808 | -1,244 | -5,975 | -3,834 | -2,951 |
| Depreciation Amortization | 155 | 77 | 2,080 | 1,850 | 1,199 |
| Accounts receivable | -698 | -610 | -116 | -158 | 492 |
| Other Working Capital | -434 | -905 | -1,446 | -1,731 | -1,217 |
| Other Operating Activity | 795 | 610 | 127 | 158 | -492 |
| Operating Cash Flow | $-2,990 | $-2,072 | $-5,331 | $-3,715 | $-2,968 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -5 | -175 | -165 | -168 |
| Purchase Sale Intangibles | -98 | -99 | -662 | -621 | -595 |
| Other Investing Activity | -98 | -99 | -662 | -621 | -595 |
| Investing Cash Flow | $-110 | $-105 | $-836 | $-786 | $-762 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,804 | N/A | 4,748 | 4,024 | 4,024 |
| Financing Cash Flow | $7,804 | $0 | $4,748 | $4,024 | $4,024 |
| Exchange Rate Effect | -80 | -34 | 856 | 97 | 326 |
| Beginning Cash Position | 9,123 | 9,123 | 9,687 | 9,687 | 9,687 |
| End Cash Position | 13,748 | 6,913 | 9,123 | 9,306 | 10,305 |
| Net Cash Flow | $4,625 | $-2,210 | $-563 | $-380 | $619 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,990 | -2,072 | -5,331 | -3,715 | -2,968 |
| Capital Expenditure | -12 | -5 | -175 | -176 | -168 |
| Free Cash Flow | -3,002 | -2,077 | -5,506 | -3,891 | -3,136 |